New Guidelines Cut Trauma Bleeding Deaths with Simple Steps

The Bleeding That Shouldn't Kill You

Every trauma surgeon knows the scene. A patient arrives in the emergency department with catastrophic injuries from a car crash, a fall, or a shooting. The team scrambles. They start IV lines, call for blood products, and begin the frantic work of keeping someone alive. And then, despite everything, the patient bleeds out.

For decades, that outcome felt almost inevitable. Severe trauma victims arrive in such a broken state that death seems like a foregone conclusion. But a growing body of evidence suggests something different: many of those deaths are preventable. Not because of some futuristic technology or miracle drug, but because of a series of simple, systematic steps that hospitals can take in the first minutes and hours after injury.

In 2023, a pan European task force of trauma specialists published the sixth edition of their guideline for managing major bleeding after trauma (Rossaint et al., 2023). The document contains 39 specific recommendations. Read them straight through, and you will notice something striking. The most impactful changes are not expensive new drugs or high tech gadgets. They are about doing the right things in the right order, measuring what matters, and stopping the bleeding before the body's own systems turn against it.

The authors found that approximately one third of patients who have experienced severe trauma arrive in hospital already in a coagulopathic state. Their blood has lost the ability to clot properly. That is not a complication. It is a ticking clock. And the difference between life and death often comes down to whether the trauma team recognizes it immediately and acts accordingly.

What Actually Kills Bleeding Trauma Patients

The standard story about trauma death goes like this: the patient loses too much blood, the heart stops pumping, and they die. That is true at the most basic level. But it misses the more interesting and actionable part of the story.

When a person suffers a major injury, the body does not just passively leak blood. It mounts a complex physiological response. The blood vessels constrict. The heart rate increases. The coagulation system activates to form clots. These are survival mechanisms. But they can also become the problem.

Traumatic coagulopathy is the name for what happens when the body's clotting system goes haywire. It is not simply that the patient has lost too many clotting factors from bleeding. The injury itself triggers a systemic inflammatory response that consumes clotting proteins, activates fibrinolysis (the system that breaks down clots), and impairs platelet function. The patient's own body starts actively undermining its ability to stop bleeding.

The Rossaint et al. (2023) guideline emphasizes that this coagulopathic state is present in roughly one third of severe trauma patients upon arrival at the hospital. That means the window for intervention is incredibly narrow. If the trauma team does not identify coagulopathy within minutes, the patient is already slipping toward a preventable death.

The guideline breaks down the management into key decision points. The first is recognition. The second is stopping the source of bleeding. The third is supporting the body's ability to clot. Each step has clear, evidence based recommendations. None of them require a Nobel Prize in biochemistry to implement.

The Simple Steps That Save Lives

Step One: Measure the Right Thing at the Right Time

The most common mistake in trauma care is guessing. A patient looks pale. Their blood pressure is low. The surgeon assumes they are bleeding and starts transfusing. But the body's clotting status is invisible to the naked eye. You cannot tell by looking at a patient whether their fibrinogen levels are adequate or whether their platelets are functional.

The Rossaint et al. (2023) guideline recommends using viscoelastic testing methods, such as thromboelastometry (ROTEM) or thromboelastography (TEG), to measure coagulation status in real time. These tests provide a graph of how the patient's blood is clotting within minutes. They show whether the problem is a lack of clotting factors, low fibrinogen, platelet dysfunction, or excessive fibrinolysis.

This is not abstract. A trauma team that uses viscoelastic testing can target their interventions precisely. Instead of giving random units of plasma and platelets and hoping for the best, they know exactly what the blood needs. The guideline states that this approach reduces mortality compared to standard coagulation tests that take much longer to return results.

Step Two: Stop the Bleeding, Not Just the Symptoms

It sounds obvious. Stop the bleeding. But in practice, trauma teams often get distracted by the numbers. The blood pressure is low, so they give fluids. The hemoglobin drops, so they give red cells. Meanwhile, the source of bleeding continues unchecked.

The guideline emphasizes damage control resuscitation. This means limiting the use of crystalloid fluids (like saline) because they dilute clotting factors and worsen coagulopathy. It means using blood products in a balanced ratio, roughly one unit of plasma for every one unit of red cells. It means giving tranexamic acid early to prevent the breakdown of clots.

Tranexamic acid deserves special attention. It is a cheap, widely available drug that inhibits fibrinolysis. The CRASH 2 trial, which the guideline cites, showed that giving tranexamic acid within three hours of injury reduces mortality from bleeding by about 15 percent. That is a massive effect for a drug that costs pennies per dose.

The Rossaint et al. (2023) guideline recommends administering tranexamic acid as soon as possible in bleeding trauma patients, ideally within three hours of injury. After that window, the benefit diminishes and may even reverse. Timing matters.

Step Three: Fix the Coagulation System Directly

Once the bleeding is controlled and the patient is receiving balanced resuscitation, the next step is to correct any specific coagulation deficits. This is where the viscoelastic testing becomes essential.

The guideline provides specific thresholds. If fibrinogen levels are below 1.5 to 2.0 grams per liter, give fibrinogen concentrate or cryoprecipitate. If platelets are below 50,000 per microliter in an actively bleeding patient, give platelet transfusion. If the viscoelastic test shows hyperfibrinolysis, give more tranexamic acid.

These are not vague suggestions. They are concrete targets. And the evidence shows that hitting these targets reduces mortality.

Why This Matters Beyond the Emergency Room

The Rossaint et al. (2023) guideline is not just for trauma surgeons. It has implications for how hospitals organize their trauma systems, how ambulances communicate with emergency departments, and how blood banks prepare for major bleeding events.

Consider the logistics. A patient with severe trauma needs blood products immediately. If the blood bank takes 30 minutes to prepare a massive transfusion pack, the patient may already be coagulopathic. The guideline recommends that hospitals have protocols in place to deliver blood products within minutes of the patient's arrival. That means pre thawed plasma, readily available platelets, and a clear communication system between the trauma team and the blood bank.

It also means training. Every member of the trauma team, from the attending surgeon to the nurse to the respiratory therapist, needs to understand the principles of damage control resuscitation. The guideline is not a secret document for specialists. It is a practical tool for everyone in the trauma bay.

What the Research Does Not Prove

The Rossaint et al. (2023) guideline is based on a systematic review of the available evidence. But the authors are honest about the limitations. Much of the evidence comes from observational studies rather than randomized controlled trials. Some recommendations are based on expert opinion rather than high quality data.

For example, the optimal ratio of plasma to red cells in massive transfusion remains debated. The guideline recommends a 1:1 ratio based on the best available evidence, but some studies suggest that a 1:2 ratio may be equivalent. The authors acknowledge this uncertainty.

Another open question is the role of whole blood transfusion. Some trauma centers are moving toward using whole blood instead of component therapy. The logic is that whole blood contains everything the patient needs in a balanced form. But the evidence is not yet strong enough for the guideline to make a firm recommendation.

There is also the question of implementation. A guideline is only as good as its uptake. Studies show that even well established guidelines are followed inconsistently. The Rossaint et al. (2023) guideline provides a clear roadmap, but it cannot force hospitals to change their practices.

The Numbers That Matter

The Rossaint et al. (2023) guideline includes 39 recommendations. But a handful stand out as the most impactful:

• ▸Measure coagulation status with viscoelastic testing within minutes of arrival
• ▸Limit crystalloid fluids and use blood products in a balanced 1:1 ratio
• ▸Give tranexamic acid within three hours of injury
• ▸Maintain fibrinogen above 1.5 to 2.0 grams per liter
• ▸Keep platelet counts above 50,000 per microliter in actively bleeding patients
• ▸Use damage control surgery for patients in hemorrhagic shock

Each of these recommendations is supported by evidence. Taken together, they form a coherent approach that has been shown to reduce preventable deaths from trauma.

What This Actually Means

• ▸If you or someone you love is in a serious accident, the hospital's ability to measure coagulation status in real time may be the difference between life and death. Ask if the trauma center uses viscoelastic testing.

• ▸The first three hours after injury are critical for tranexamic acid. If you are in a position to advocate for a patient, ensure that this drug is given early. Every minute counts.

• ▸Blood products are better than IV fluids. If a trauma patient is bleeding heavily, they need plasma and red cells, not bags of saline. The old practice of "loading" with crystalloid before giving blood is now known to be harmful.

• ▸Damage control surgery is not about doing less. It is about doing the right thing at the right time. A patient in shock should have their bleeding controlled quickly, not undergo a lengthy definitive repair.

• ▸The guideline is a living document. The Rossaint et al. (2023) sixth edition builds on previous versions, and future editions will incorporate new evidence. Trauma care is improving, and the improvements are measurable.

The bleeding trauma patient has always been one of the most challenging cases in medicine. The body is breaking down in real time. The clock is running. But the Rossaint et al. (2023) guideline shows that we are no longer guessing. We have a map. We have tools. And we have evidence that simple, systematic steps can cut the number of preventable deaths.

That is not a small thing. That is thousands of people who would have died but will now survive. And all it took was paying attention to the blood.